News

Two clinical trials evaluating cemsidomide — an oral therapy candidate from C4 Therapeutics (C4T) that aims to limit cancer growth — in people with…

Silexion Therapeutics has launched a Phase 2/3 clinical trial testing its experimental therapy SIL204 in combination with standard-of-care chemotherapy in people with pancreatic…

The U.S. Food and Drug Administration (FDA) has granted conditional approval to iberdomide, an oral medication to be used in combination with an antibody-based…

Scientists have developed a new human cell model to study rare cases of cervical cancer that aren’t associated with human papillomavirus (HPV) infection. Few laboratory…

When glucose is scarce, fat cells can produce beta-OHB, a molecule that helps myeloma cells survive metabolic stress, a new study found. The study,…

Treatments using gamma delta T-cells, a type of immune cell, hold promise for treating glioblastoma, scientists said, though they added that much more research is…

An international group of researchers is teaming up to develop a myeloma treatment that harnesses the cancer-killing abilities of natural killer (NK) cells. As…

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the experimental therapy enzomenib (DSP-5336) as a potential treatment for …

More than 40% of patients in a Phase 1 clinical trial of myeloma treatment cevostamab responded to the drug, meaning their cancer burden was…

The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to Eli Lilly’s experimental medication olomorasib as a potential treatment for previously…